Jo-Anne H. Young

Jo-Anne H. Young (née van Burik) is an American physician, scientist, and Editor-in-Chief of Clinical Microbiology Reviews, published by the American Society for Microbiology.[1][2]

Her expertise is in the areas of transplantation infectious diseases, infections of the immune compromised host, and clinical mycology and virology.[3][4][5][6]

She is Medical Director of the Adult Transplant Infectious Disease Program at the University of Minnesota.[7][8] Other responsibilities that Young has with the University of Minnesota include the Institutional Review Board, Co-chair of the Supportive Care/Infectious Disease/Toxicities Site Team for the Cancer Center, Physician Informatics Committee at the Medical Center, and Clinical Service Unit Board in the Department of Medicine.[9][10] Before coming to the University of Minnesota in 1999, she worked at the Fred Hutchinson Cancer Research Center with the University of Washington in Seattle, from 1993 to 1998. She completed an internal medicine residency at Vanderbilt University Medical Center in Nashville, Tennessee, from 1990 to 1993. She completed her M.D. degree at Case Western Reserve University in Cleveland, Ohio, in 1990.

References

  1. ↑ Young, Jo-Anne. "Editor-in-Chief". Clinical Microbiology Reviews, Editorial Board. American Society for Microbiology. Retrieved 19 November 2015.
  2. ↑ "Clinical Microbiology Reviews". Clinical Microbiology Reviews. American Society for Microbiology. Retrieved 18 November 2015.
  3. ↑ van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP (2006). "Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases". Clin Infect Dis. 42 (7): e61–5. doi:10.1086/500212. PMID 16511748.
  4. ↑ van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA (2007). "Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease". Biol Blood Marrow Transplant. 13 (12): 1487–98. doi:10.1016/j.bbmt.2007.08.049. PMID 18022579.
  5. ↑ van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ; National Institute of Allergy and Infectious Diseases Mycoses Study Group (2004). "Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation". Clin Infect Dis. 39 (10): 1407–16. doi:10.1086/422312. PMID 15546073.
  6. ↑ van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ (2007). "Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients". Biol Blood Marrow Transplant. 7 (12): 674–9. doi:10.1053/bbmt.2001.v7.pm11787530. PMID 11787530.
  7. ↑ Young, Jo-Anne. "Professor of Medicine; Infectious Disease and Transplant Physician". Medical School. University of Minnesota. Retrieved 17 November 2015.
  8. ↑ Young, Jo-Anne. "Infectious Disease Physician". University of Minnesota Medical Center. Fairview Health Services. Retrieved 17 November 2015.
  9. ↑ Young, Jo-Anne. "Infectious Disease Physician". U.S News and World Report Health. U.S. News & World Report LP. Retrieved 17 November 2015.
  10. ↑ Young, Jo-Anne. "Infectious Disease Physician" (PDF). Complete List of Joel Meyers Infectious Disease Endowment Scholars. Fred Hutchinson Cancer Research Center. Retrieved 17 November 2015.
This article is issued from Wikipedia - version of the 11/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.